Table 3. Proportion BKPyV viremia and BKPyVAN based on median trough levels.
3 months | Tac median >9.5ug/l | Tac median < 9.5ug/l | P value | CsA median >183.5ug/l | CsA median <183.5ug/l | P value |
BKPyV viremia, n (%) | 20 (50) | 20 (50) | 1 | 21 (56.8) | 16 (43.2) | 0.35 |
BKPyVAN, n (%) | 6 (54,5) | 5 (45,5) | 0.76 | 3 (75) | 1 (25) | 0.31 |
12 months | Tac median >8.4ug/l | Tac median <8.4ug/l | P value | CsA median >163.5ug/l | CsA median <163.5ug/l | P value |
BKPyV viremia, n (%) | 14 (40) | 21 (60) | 0.16 | 20 (60.6) | 13 (39.4) | 0.17 |
BKPyVAN, n (%) | 3 (50) | 3 (50) | 0.98 | 3 (60) | 2 (40) | 0.65 |
Chi squared tests were used to compare the proportion of BKPyV viremia and BKPyVAN in patients with trough levels higher and lower than median at 3 months and 12 months after renal transplantation.